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Abstract
Background: Early markers of diabetic autonomic neuropathy (DAN) in an electrocardiogram (ECG) include
elevated R wave amplitudes, widening of QTc intervals and decreased heart rate variability (HRV). The severity of
DAN has a direct relationship with mortality risk. Aerobic exercise training is a common recommendation for the
delay and possible reversal of cardiac dysfunction. Limited research exists on ECG measures for the evaluation of
aerobic exercise training in Zucker Diabetic Fatty (ZDF) rat, a model of type 2 diabetes. The objective of this study
was to assess whether aerobic exercise training may attenuate diabetes induced ECG changes.
Methods: Male ZDF (obese fa/fa) and control Zucker (lean fa/+) rats were assigned to 4 groups: sedentary control
(SC), sedentary diabetic (SD), exercised control (EC) and exercised diabetic (ED). The exercised groups began 7
weeks of treadmill training after the development of diabetes in the ED group. Baseline (prior to the training) and
termination measurements included body weight, heart weight, blood glucose and glycated hemoglobin levels
and ECG parameters. One way repeated measures ANOVA (group) analyzed within and between subject
differences and interactions. Pearson coefficients and descriptive statistics described variable relationships and
animal characteristics.
Results: Diabetes caused crucial changes in R wave amplitudes (p < 0.001), heart rate variability (p < 0.01), QT
intervals (p < 0.001) and QTc intervals (p < 0.001). R wave amplitude augmentation in SD rats from baseline to
termination was ameliorated by exercise, resulting in R wave amplitude changes in ED animals similar to control
rats. Aerobic exercise training neither attenuated QT or QTc interval prolongation nor restored decreases in HRV in
diabetic rats.
Conclusion: This study revealed alterations in R wave amplitudes, HRV, QT and QTc intervals in ZDF rats. Of these
changes, aerobic exercise training was able to correct R wave amplitude changes. In addition, exercise has
beneficial effect in this diabetic rat model in regards to ECG correlates of left ventricular mass.
Background
Cardiovascular disease (CVD) accounts for the majority
of deaths for people with type 2 diabetes mellitus. CVD
is a broad term which includes any condition causing
pathological changes in blood vessels, cardiac muscle or
valves and cardiac rhythm. The electrocardiogram
(ECG) offers a quick, non-invasive clinical and research
screen for the early detection of CVD.
Electrocardiographic changes in raw and corrected QT
intervals and R wave amplitudes are early indicators of
evolving CVD and increased cardiovascular risk. Pro-
longed QT and QTc intervals are considered reliable
predictors of heart disease and fatal ventricular arrhyth-
mias [1-3]. A positive linear relationship exists between
QTc interval prolongation and diabetic cardiac auto-
nomic neuropathy (DAN) severity in diabetic population
[4]. Heart rate variability (HRV), one indicator of DAN,
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tality risk [5]. QT and QTc interval abnormalities reflect
changes in cardiac architecture. A positive correlation
between QT or QTc interval prolongation and left ven-
tricular (LV) mass has been reported [6-8]. LV hypertro-
phy presents as exaggerated R wave amplitudes on ECG
recordings. Elevated R wave amplitudes are an indepen-
dent risk factor for cardiovascular events [9]. LV hyper-
trophy and QT interval alterations coupled with
decreased cardiac function are commonly observed with
diabetes related CVD [10].
Non pharmacological interventions for CVD focus pri-
marily on lifestyle changes with physical activity as the
primary focus and a risk reduction strategy. Physical
activity reduces QTc interval prolongation and cardiac
dysfunction in healthy subjects [11,12]. Exercise lowers
heart rate and increases HRV in healthy and diseased
populations [13,14]. Physical activity can serve as potent
prescription in the delay and attenuation of the CVD
complications for persons with type 2 diabetes but addi-
tional comparative studies are needed regarding the car-
diac response to exercise under diabetic conditions at
various time points of the disease.
T h eZ u c k e rD i a b e t i cF a t t y( Z D F )r a ti sam o d e lo f
type 2 diabetes. The ZDF rat develops hyperglycemia
and hyperlipidemia by week 8 and overt diabetes by
week 12. The progression mimics the obesity-related
insulin resistance and inflammation seen in humans
[15,16]. The ZDF rat is commonly used to investigate
prevention of diabetes; however, research related to the
diabetic heart disease including ECG studies with this
animal model is limited. We hypothesized that ECG
changes occur in ZDF rats early in the disease process
and aerobic exercise training is able to alleviate the
changes. We detected changes in ECG parameters that
were partially corrected by exercise training. Our find-
ings add to the characterization of the ZDF model for
studying type 2 diabetes effects on the heart and explore
the benefits of an early exercise intervention in the pre-
sentation and progression of diabetes related CVD.
Methods
Animals
Male Zucker Diabetic Fatty (fa/fa) rats of 11 weeks were
utilized for the study. Male lean, age-matched Zucker
(fa/+) rats (both from Charles River Laboratory, Saint
Louis, MO) served as non-diabetic controls. The animals
were allowed food and water ad libitum and were placed
on a 12:12 light-dark cycle. As per vendor’s recommen-
dations, the animals were fed Purina 5008 diet during
the entire study for the development of a disease pro-
cess resembling type 2 diabetes and its complications.
All animal procedures were performed according to the
University of Kansas Medical Center Institutional
Animal Care and Use Committee guidelines and an
approved Animal Care and Use Protocol.
Measurements
Body weights and blood glucose levels were measured
weekly on all animals. Blood glucose levels were mea-
sured from rat tail using Accu-Check Active meter
(Roche Diagnostics, Indianapolis, IN). Glycated hemo-
globin (HbA1c) levels were measured at the end of the
experiment using antibody-based A1cNow meter
(Metrika, Sunnyvale, CA). When rats had blood glucose
or HbA1c levels higher than detectable by the method
used, we used the highest detectable value (600 mmol/L
or 13%, respectively) for statistical purposes. Animals
were killed within 36 hours of the last exercise training
episode.
Aerobic exercise training
The rats started a treadmill exercise program at
12 weeks of age, immediately after the onset of diabetes,
and continued exercising for 7 weeks. Four groups of
rats were used: sedentary control (SC, n = 12), sedentary
diabetic (SD, n = 10), exercised control (EC, n = 10) and
exercised diabetic (ED, n = 12). This training protocol
has been published by our group previously for a rat
model of type 1 diabetes [17] and was adapted for the
o b e s ed i a b e t i cr a t sa st h e yw e r eu n a b l et op e r f o r ma t
that intensity level. During the first week of training the
animals ran at 10 m/min with time increased from
10 min per day to 40 min per day at the end of the
week. The progression allowed the rats to acclimate to
the treadmill. Starting at week two and until the com-
pletion of the training session the rats ran at 15 m/min,
for 40 minutes, 5 days per week. In order to accommo-
date for the disease progression in the diabetic rats, any
animals showing signs of fatigue were allowed breaks of
a few minutes until they were able to continue, for a
total run time of 40 min per day. All rats assigned to
t h ee x e r c i s eg r o u p sc o m p l e t e dt h ee x e r c i s et r a i n i n g
protocol.
Electrocardiogram (ECG) assessment
Animals received ketamine (60 mg/kg) and xylazine
(7 mg/kg) prior to the resting ECG recording. ECG
leads I, II, III, aVR, aVL, aVF were recorded with surface
electrodes (ADInstruments, Colorado Springs, CO).
Measurements were collected at baseline, prior to train-
ing and after 7 weeks of exercise training. The mean
value for each rat was obtained from four values consist-
ing of four consecutive cardiac cycles using LabChart
software (ADInstruments, Colorado Springs, CO).
Corrected QT (QTC) was calculated with mean values
and the Bazett’sF o r m u l a( Q T c =Q TI n t e r v a l / √ (RR
interval) [18]. The heart rate (bpm) for each animal was
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rate variability (HRV) was measured as the standard
deviation of the RR intervals.
Statistical analysis
Descriptive statistics was performed on animals’ means
for each group. One way repeated measures ANOVA
(group) analyzed within and between subject differences
and interactions. Single time point measurements or
change scores were completed with one way ANOVA
(group) with Least Significant Difference (LSD) post-hoc
analysis. Pearson correlations were utilized for relation-
ship values. Partial eta squared values are reported for
the proportion of total variability attributed to a factor.
Statistics were conducted with PASW Version 17 soft-
ware (SPSS Inc, Chicago, IL, USA). Significance was
measured at p < 0.05. Results are presented as means ±
standard errors. The effect size of baseline body weights
was large with Cohen’s d = 2.8 and power was greater
than 90% with sample sizes of 10-12 per group.
Results
Animal characteristics
A summary of animal characteristics are reported in
Table 1 and weekly body weights are plotted in Figure 1.
A significant difference in body weight between diabetic
and control animals was observed at baseline and termi-
nation time points, F(3,40) = 19.37; p <0 . 0 0 1 .T h em e a n
difference between baseline and termination body
weights indicated that control animals gained approxi-
mately 14% of their baseline body weights compared to a
5% gain for diabetic animals, p < 0.001. Diabetic animals
outweighed their control counterparts by 9-12% at termi-
nation even with the discrepancy in weight gain.
Although ED rats weighed less than SD animals at the
termination, the ED rats were significantly heavier than
SC and EC animals, p = 0.016 and p < 0.001 respectively.
However, aging accounted for 64% of the variance in
body weights as evident by average weight gains of 16-57
grams in all animal groups, F(1,39) = 71.29; p <0 . 0 0 1 .A
moderate relationship between body weight and blood
glucose levels existed at the baseline r(44) = 0.56; p <
0.001 and termination r(44) = 0.41; p < 0.01. The main
effect of the group on blood glucose levels was modified
by aging, F(1,39) = 3.02; p < 0.04. Although all animals
had an increase in blood glucose levels, ED animals had
only a 10% change compared to the 21% change of SD
rats. HbA1C levels were elevated in diabetic groups com-
pared to control groups, F(3,40) = 99.27; p < 0.001. Exer-
cise did not attenuate HbA1C levels in ED animals, p =
0.92. Hyperglycemia is a factor in left ventricular hyper-
trophy development and progression but a correlation
between A1C levels and heart weight/body weight ratios
was not observed, r(44) = -0.17 p = 0.27. Heart weight/
body weight ratios were similar for the animal groups,
F(3,40) = 1.39; p = 0.26.
ECG wave amplitudes
R wave amplitude
R wave amplitudes were similar for groups at baseline
except for the SD groups, F(3,40) = 15.16, p < 0.001.
Therefore, statistical analyses used the change value for
R wave amplitude to account for the difference at baseline.
Gains in R wave amplitudes from baseline to termination
of the experiment were only observed in the SD animals
as reported in Figure 2. The SD rats had a 17% increase in
R wave amplitude, suggesting left ventricular hypertrophy.
A reduction in R wave amplitude was found in ED animals
at termination. ED rats had change values similar to SC
and EC animals, F(3,40) = 4.13, p =0 . 8 4a n dp = 0.87.
T wave amplitude
Due to the significant differences between diabetic
groups at baseline, we analyzed the change of T wave
amplitudes from baseline to termination (Figure 3).
T wave amplitudes changes were similar in the four
groups, F(3,40) = 1.81, p = 0.16.
Table 1 Animal characteristics at baseline and termination
Sedentary Control
(SC) n = 10
Sedentary Diabetic
(SD) n = 12
Exercised Control
(EC) n = 12
Exercised Diabetic
(ED) n = 10
Baseline Term Baseline Term Baseline Term Baseline Term
Body weight (g) 326 ± 13 381 ± 13 409 ± 34
a, b, f 457 ± 41
a, b, f 309 ± 30
c, f 366 ± 22
c, f 374 ± 24
b, c, e 390 ± 23
b, c
Blood glucose (mmol/L) 115 ± 9 145 ± 9 433 ± 144
a, f 579 ± 35
a, f 111 ± 11
c, f 156 ± 12
c, f 491 ± 136
c 584 ± 22
c, e
HbA1c (%) ND 4.2 ± 0.3 ND 13.0 ± 0.0
a, f ND 4.7 ± 0.3
c, d, f ND 13.0 ± 0.0
c, e
Heart rate (bpm) 355 ± 148 416 ± 190 393 ± 68 423 ± 84 358 ± 139 408 ± 100 397 ± 73 413 ± 81
Heart weight (g) 1.24 ± 0.12 1.29 ± 0.09
f 1.15 ± 0.08
d, f 1.22 ± 0.10
Heart weight/Body
weight (mg/g)
3.27 ± 0.04 3.02 ± 0.03 3.16 ± 0.02 3.09 ± 0.03
Data are means ± SEs for each group with n as indicated. Statistical significance: Between group differences at baseline or termination (term) of p ≤ 0.05; ND -
not determined;
aSC vs SD,
bSD vs ED,
cEC vs ED,
dSC vs EC,
eSC vs ED and
fSD vs EC.
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Figure 1 Weekly mean body weight measurements. Data are means ± SEs for each group with n = 12 for sedentary diabetic (SD) and
exercised control (EC); and n = 10 for sedentary control (SC) and exercise diabetic (ED) rats.
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Figure 2 Mean R wave amplitude changes. Data are means ± SEs for each group with n = 12 for sedentary diabetic (SD) and exercised
control (EC); and n = 10 for sedentary control (SC) and exercise diabetic (ED) rats. Statistical significance with p ≤ 0.05;
aSC vs SD,
bSD vs ED and
fSD vs EC.
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P wave amplitudes were similar between control and
diabetic animals at baseline and termination, F(3,40) =
0.40, p = 0.99 (Figure 4). The amplitudes were decreased
between baseline and termination in all four animal
groups, as evident by time modifying the group effect, F
(1,40) = 25.05, p < 0.001.
ECG intervals
RR intervals
A significant shortening of RR intervals and increased
heart rates was observed in SD group at baseline when
compared to the SC group, F(1,38) = 8.83, p < 0.01
(Table 2). At termination, only a trend toward tachycar-
dia was observed SD animals compared to SC animals,
F(3,36) = 2.79, p = 0.06. Exercise did not reverse the
heart rate pattern for diabetic animals, p = 0.92. Table 2
shows that all animal groups had various levels of RR
interval shortening at termination, but statistically an
aging effect was not observed, F(1,38) = 0.34, p = 0.56.
Decreased HRV was observed in all diabetic animals,
sedentary and exercised compared to control animals F
(1,38) = 1662.23, p < 0.01. HRV was not improved with
exercise, p = 0.91 as calculated with the termination RR
intervals of the ED animals.
QRS intervals
Widening of QRS intervals, a sign of abnormal intraven-
tricular conduction, was found at baseline in diabetic
animals, F(3,40) = 3.72, p < 0.01 (Table 2). An 18%
difference existed in the duration of QRS intervals
between the SC and SD animals. At termination, QRS
intervals increased 6-9% for SD animals in comparison
to 27-29% increases in SC animals. These changes
implied that aging interacted with the main effect of the
group, F(1,41) = 16.78, p < 0.001 and accounted for 29%
of the variability of QRS intervals at termination. There-
fore, the difference between SC and SD animals at base-
l i n ew a sl o s ta tt e r m i n a t i o n ,F(3,40) = 0.57, p =0 . 6 4 .
An impact of exercise on QRS intervals was not
observed in the EC and ED animals.
QT and QTc intervals
SD animals presented with QT intervals (a measure of
ventricular repolarization) 31% wider than SC animals at
baseline, F(3,40) = 9.37, p < 0.001 (Table 2). After
7 weeks of exercise, QT intervals in ED animals
remained widened, F(3,40) = 14.13, p =0 . 8 5 .A tt e r m i -
nation, the difference between SC and SD animals
decreased to 21%. Aging accounted for 20% of the varia-
bility in termination QT intervals, but the group effect
of diabetes accounted for 51% of the variability.
An interaction between aging and group factors was not
significant, and QT intervals were not affected by exer-
cise in control or diabetic animals, p = 0.91 and p = 0.61.
QTc intervals (QT intervals corrected with RR inter-
vals) were analyzed for an evaluation independent of
heart rate. SD animals displayed significant widening of
QTc intervals compared to SC animals, F(1,42) = 10.58,
p < 0.001 (Table 2). Exercise did not attenuate the
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Figure 3 Mean T wave amplitudes. Data are means ± SEs for each group with n = 12 for sedentary diabetic (SD) and exercised control (EC);
and n = 10 for sedentary control (SC) and exercise diabetic (ED) rats. Statistical significance with p ≤ 0.05;
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Compared to QT intervals, aging accounted for 85% of
the variability in QTc intervals and 43% was due to
group effects at termination. The interaction between
time and group was significant, F(3,40) = 4.54, p < 0.01.
PR intervals
Baseline measurements revealed significant prolongation
of PR intervals in SD animals compared to SC animals,
F(1,39) = 5.40, p < 0.01 (Table 2). At termination, the
difference between groups was not observed, p =0 . 3 4 .
Exercise did not impact PR intervals in EC and ED
animals.
Discussion
CVD risk is increased up to four-fold in people with dia-
betes compared with their nondiabetic counterparts [19].
Researchers are aggressively trying to identify early detec-
tion methods and explore the factors contributing to
diabetes related heart disease. The ZDF rat model is rou-
tinely used to investigate physiological and molecular
hypotheses regarding diabetes and its related complica-
tions. Reports are available indicating cardiac dysfunction
in the ZDF rat established primarily with hemodynamic
or echocardiographic measurements or through experi-
ments on the isolated heart [20-23]. However, limited
information exists about the ECG changes that occur in
the ZDF rat and its response to physical activity, specifi-
cally to aerobic exercise that is commonly recommended
for those at risk or diagnosed with diabetes related heart
disease [24,25]. Our project aimed to address this gap in
the current literature.
Although we did not measure autonomic function
directly, ECG indicators of autonomic dysfunction were
observed in the ZDF rats at baseline with HRV altera-
tions, tachycardia and QT interval prolongation. Auto-
nomic innervations control HRV and cardiac function
through a delicate balance of sympathetic and parasym-
pathetic responses. Diabetes stimulates the sympathetic
nervous system initially but prolonged exposure to
hyperglycemia and elevated catecholamine levels cause a
decrease in adrenergic receptors [26]. As diabetes
creates a sympathetic predominance, it also produces a
corresponding parasympathetic imbalance by denerva-
tion of the vagus nerve. Subclinical symptoms of DAN,
primarily decreased HRV, are believed to appear in
humans within one year of type 2 diabetes diagnosis
and clinical presentations may not emerge until years
into the diagnosis [27]. Bergstrom et al identified symp-
toms of DAN in type 1 diabetic patients with durations
of diabetes as low as two months [28]. In our animal
study, diminished HRV was noted in ECG recordings as
early as within one week of diabetes onset for the ZDF.
Clinical DAN symptoms include resting tachycardia,
exercise intolerance and orthostatic hypotension and
heart rate syndromes [29]. Tachycardia was observed in
diabetic animals at baseline, within a week of diabetes
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Sedentary Control
(SC) n = 10
Sedentary Diabetic
(SD) n = 12
Exercised Control
(EC) n = 12
Exercised Diabetic
(ED) n = 10
Baseline Term Baseline Term Baseline Term Baseline Term
RR interval (sec) 0.195 ± 0.077 0.152 ± 0.041 0.158 ± 0.033 0.132 ± 0.012 0.191 ± 0.073 0.158 ± 0.048 0.157 ± 0.036 0.135 ± 0.012
QRS interval (sec) 0.016 ± 0.005 0.022 ± 0.002 0.020 ± 0.002
a, f 0.022 ± 0.004 0.016 ± 0.004
c, f 0.023 ± 0.003 0.020 ± 0.002
c, e 0.021 ± 0.004
QT interval (sec) 0.043 ± 0.012 0.040 ± 0.005 0.064 ± 0.013
a, f 0.051 ± 0.012
a, f 0.045 ± 0.012
c, f 0.041 ± 0.006
c, f 0.062 ± 0.011
c, e 0.052 ± 0.013
c, e
QTc interval (sec) 0.105 ± 0.043 0.105 ± 0.020 0.163 ± 0.033
a, f 0.134 ± 0.034
a, f 0.111 ± 0.043
c, f 0.106 ± 0.018
c, f 0.159 ± 0.026
c, e 0.134 ± 0.037
c, e
PR interval (sec) 0.032 ± 0.010 0.030 ± 0.006 0.045 ± 0.011
a, f 0.034 ± 0.008 0.036 ± 0.012
c, f 0.030 ± 0.005 0.046 ± 0.011
c, e 0.034 ± 0.009
Data are means ± SEs for each group with n as indicated. Statistical significance: Between group differences at baseline or termination (term) of p ≤ 0.05;
aSC vs SD,
cEC vs ED,
eSC vs ED and
fSD vs EC.
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0onset. Tachycardia is also a common finding in humans
with uncontrolled diabetes [30]. Similarly, our animals
were not treated for their hyperglycemia as evident by
blood glucose and HbA1C levels. The role of tachycar-
dia is controversial because research indicates that it
may be a diabetic complication or a causative factor of
diabetes. Nagaya et al argue that elevated resting heart
rates and systolic blood pressure increase the risk for
type 2 diabetes [31]. Another work by the same group
indicated that prolonged QTc intervals were also an
independent risk factor for the development of diabetes
[32]. Our analysis indicates that widening of QTc inter-
vals was present with the onset of diabetes at twelve
weeks of age in ZDF rats. Thus abnormalities of ventri-
cular repolarization are present at an early stage of dia-
betes in this model. An earlier time study would be
useful to verify the presence of tachycardia and QTc
interval prolongation during a pre-diabetic state. Of
interest, several ECG parameters in our study showed
an impact of aging, in agreement with findings by others
[33] indicating cardiac and renal changes in the ZDF rat
model with aging, up to 36 months.
P wave amplitudes were unaffected with the onset of
diabetes. Future studies need to investigate the relation-
ship between the dispersion of the P wave and the onset
of diabetes. Obesity is commonly linked to diabetes and
is reported to increase the dispersion of the P wave [34].
PR intervals were widened in diabetic animals at base-
line, but normalized at termination. PR intervals are
commonly associated with atrial fibrillation [35,36];
however our ECG assessments of diabetic animals did
not indicate atrial dysfunction. Diabetes and exercise
appeared to have no effect on T wave amplitudes.
T wave amplitudes were skewed at baseline and there-
fore change scores were used for analysis. However, the
morphology of the T wave has shown to have prognos-
tic value for CVD, not amplitude changes [37,38].
After seven weeks of aerobic exercise, ED animals
showed R wave amplitudes comparable to control ani-
mals. Only SD animals had an increase in R wave ampli-
tude. Hyperglycemia is associated with left ventricular
hypertrophy in type 2 diabetes [39]. The increase in R
wave amplitude may indicate a change in left ventricular
mass. With diabetes, pathological hypertrophy results
from myocardial damage and fibrosis [40-42]. Fibrosis
affects the filling and contractility of the ventricles. Sub-
sequently, cardiac dysfunction presents as decreased
activity tolerance, ejection fraction, cardiac output and
heart failure [43]. However, other factors can alter R
wave amplitudes, including electrical axis deviations,
altered electrodes position and differences in chest wall
thickness. Ideally, the ECG should be correlated with an
echocardiography. Unfortunately, we were unable to use
echocardiography approach, thus we recognize this as a
limitation of this study. In analyzing other indications of
heart hypertrophy, we found no difference in the heart
weight/body weight ratio in our study. Alternatively, the
LV weight/tibial length ratio has been validated as an
index of cardiac hypertrophy in mature rats [44]. Due to
the fact that the onset of diabetes in the ZDF rat occurs
early in their age, we were restricted to using relatively
young animals that were in the latter stages of their
growth phase. Thus, normalizing heart size to the chan-
ging tibial bone length during growth may not have pro-
vided an accurate estimation in our study. Darmellah et
al reported that normalization of the heart weight per
body weight or tibial length resulted in similar measure-
ments of cardiac hypertrophy in Goto-Kakizaki animals,
another rat model of type 2 diabetes [45].
Aerobic exercise did not impact the hyperglycemia.
Exercise is postulated to improve glucose uptake and
decrease lipid accumulation in persons with controlled
diabetes but the protective mechanism of exercise is lost
if hyperglycemia persist [46]. A comparative study of
fenobirate and metformin validated the role of lipid oxi-
dation in the development and progression of diabetes
related heart disease, with fenobirate decreasing trigly-
cerides content and fibrosis in diabetic myocardium
[47]. The switch in myocardial substrate from glucose to
fatty acids has been shown to result in systolic and dia-
stolic dysfunction in the ZDF model [48]. Exercise train-
ing has also been suggested to improve microcirculation
through enhanced endothelial function [49] through
normalizing glycemic levels. However, the severity of
diabetes will determine if the body can adapt to the
demands of exercise or regional flow has already been
compromised beyond recovery [50]. Microcirculatory
disturbances or small vessel disease may lead to declines
in myocardial blood flow which could influence ECG
parameters [51].
A 31% difference in QT intervals was reported
between SC and SD animals at baseline. We hypothesize
that cardiac remodeling was already in the process in
the SD rats when we were taking the baseline measures,
prior to any training, due to animals already displaying
hyperglycemia and obesity associated with the genotype,
in contrast to the SC rat. QTc intervals did not respond
to exercise, but the chronic tachycardia shortened the
intervals as a compensatory effect. Commonly, exercise
may cause a decrease in heart rate and increased ventri-
cular relaxation which presents as longer QT intervals.
A study investigating the effects of a seven month
endurance training program in dogs revealed an increase
in QT intervals [52]. An acute resistance exercise
resulted in a similar effect on QTc intervals [53]. Since
our obese, diabetic animals were showing early signs of
autonomic disturbance, exercise tolerance was lowered
and animals required frequent rest breaks during our
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might not have been sufficient for QTc interval adapta-
tion. In a future study we will investigate longer dura-
tions of exercise training to see whether it may return
diabetic animals to normal heart rates or restore HRV.
Pagkalos et al reported improvements in cardiac auto-
nomic function with six months of aerobic exercise
training [54]. Another alternative is the evaluation of
HRV during post-exercise recovery. Training may not
affect resting HRV, but the benefits may be evident with
the post-exercise recovery. This conclusion is supported
by a study investigating cardiac autonomic function in
women with and without diabetes [55].
Conclusions
In summary, our investigation proved that ECG altera-
tions do occur with diabetes in the ZDF rat. The altera-
tions include prolongation of the QTc interval and
tachycardia which constitute important electrophysiolo-
gic alterations in this animal model of diabetes. These
modifications coupled with high R wave amplitude illus-
trate the early cardiac anatomic and electrophysiologic
alterations in this diabetic model. After seven weeks of
exercise training, R wave amplitude changes in diabetes
were similar to control animals from baseline to termi-
nation. However, aging may have an impact on several
ECG parameters and the ZDF model showed changes in
atrial and ventricular conduction possibly due to an
interaction of aging and group effects. Future studies are
needed to investigate ECG changes in the ZDF model
before the onset of diabetes which will provide addi-
tional information about the use of QTc intervals and
HRV in the early detection of DAN.
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